Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

266 Yeap SS, Othman AZ, Zain AA, Chan SP. Vitamin D levels: its relationship to bone
mineral density response and disease activity in premenopausal Malaysian systemic lupus
erythematosus patients on corticosteroids. Int J Rheum Dis 2012; 15: 17–24.
267 Petri M, Bello KJ, Fang H, Magder LS. Vitamin D in systemic lupus erythematosus:
modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis
Rheum 2013; 65: 1865–1871.
268 Kingsmore S, Thompson J, Crockard A, Todd D, McKirgan J, Patterson C et al. of
circulating immune complexes containing IgG, IgM, IgA and IgE by flow cytometry:
correlation with disease activity in patients with systemic lupus erythematosus. J Clin Lab
Immunol 1989; 30: 45–52.
269 Inman R, Fong J, Pussell B, Ryan P, Hughes G. The C1q binding assay in systemic lupus
erythematosus. Arthritis Rheum 1980; 23: 1282–1286.
270 Calvo-Alén J, Silva-Fernández L, Úcar-Angulo E, Pego-Reigosa JM, Olivé A, Martínez-
Fernández C et al. SER consensus statement on the use of biologic therapy for systemic
lupus erythematosus. Reumatol Clin 2013; 9: 281–96.
271 Vitali C, Bencivelli W, Isenberf D, Smolen J, Snaith M, Sciuto M et al. Disease activity in
systemic lupus erythematosus: report of the Consensus Study Group of the European
Workshop for Rheumatology Research. II. Identification of the. Clin Exp Rheumatol
Rheumatol 1991; 10: 541–547.
272 Isenberg D, Bacon P, Bombardier C, Gladman D, Goldsmith C, Kalunian K et al. Criteria
for assessing disease activity in systemic lupus erythematosus. J Rheumatol 1989; 16: 1395–
1396.
273 Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Gladman D et al. Randomized
Clinical Trials and Longitudinal Observational Studies in Systemic Lupus
Erythematosus : Consensus on a Preliminary Core Set of Outcome Domains. J
Rheumatol 1999; 26: 504–507.
274 Fortin P, Abrahamowicz M, Clarke A, Neville C, Du Berger R, Fraenkel L et al. Do lupus
disease activity measures detect clinically important change? J Rheumatol 2000; 27: 1421–
1428.
275 Arce-Salinas A, Cardiel M. Validity of retrospective disease activity assessment in
systemic lupus erythematosus. J Rheumatol 1996; 23: 846–849.
276 Uribe A, Vilá L, McGwin G, Sanchez M, Reveille J, Alarcón G. The Systemic Lupus
Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity
Index (SLEDAI), and a modified SLEDAI-2K are adequate. J Rheumatol 2004; 31: 1934–
1940.
277 Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR et al.
Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med
2005; 353: 2550–2558.
GUÍA DE PRÁCTICA CLÍNICA SOBRE LUPUS ERITEMATOSO SISTÉMICO 455